Released on = April 18, 2006, 9:54 pm

Press Release Author = RNCOS

Industry = Biotech

Press Release Summary = RNCOS Research:
(http://www.marketsmonitor.com/category/Biotech14.html) The Indian biotech industry
has failed to get support from the financial budget on the tax front and
non-relaxation of export obligations for newly incorporated biotech companies.

Press Release Body = RNCOS Research:
(http://www.marketsmonitor.com/category/Biotech14.html) The financial budget of
India for the year 2006 has caused reasons to disappoint its biotech sector. The
first shortfall was in dowsing expectations on the tax structure. While currently
only costs of Indian patent filings are included in weighted tax deductions, the
biotech sector now wants costs of international patent filings also to be included.

The second shortfall pertains to restraining taxes on technology transfers and
technology licensing on which the biotech industry relies heavily to launch new
technologies. This dependence is more as world biotech companies usher advanced
medicinal and agricultural techniques into the country. So the biotech industry
wants exemptions on withholding taxes on these.

Entrepreneurs argue that the biotech sector needs this kind of support to compete
with countries like China, Singapore, Korea and Eastern Europe. The industry
therefore hopes that its demand would be met by the new national biotech policy that
is to be announced later this year.

The financial budget has also disappointed the industry by not relaxing export
obligations for newly formed biotech companies in the biotech “parks” coming up in
all economic zones of the country.

Recently, several state governments such as in Maharashtra, Andhra Pradesh and
Karnataka have taken proactive initiatives to promote biotechnology by implementing
different biotechnology policies. These policies focus on setting up Biotech Parks,
Incubators, Centers of Biotech Excellence and providing fiscal incentives to
investors.

A market research report named “Indian Biotechnology Market Outlook (2006)” prepared
by RNCOS gives a detailed analysis of the Indian biotech market structure and
conditions. It also delineates the initiatives and policies of central and state
governments.

Prior to this, the report assesses the Indian biotechnology market for 2005 in terms
of size, demand, domestic market and exports. It also forecasts for the same till
2010. An intensive SWOT analysis is also covered in the report. The analysts discuss
about the future of biotechnology in India as also how the government initiatives
and resulting regulations are affecting the industry.

Finally the report lists company profiles of 20 major players in biotech industry
including Shantha Biotechnics, Biocon, Bharat Biotech, Wockhardt, Serum Institute of
India, Zydus Cadila, and Aventis Pharma.

About RNCOS:
RNCOS, formed in 2002, offers Market Research Reports via MarketsMonitor for your
business needs and aims to put an end to your information pursuit. Our expertise in
gathering global business information for industry research, corporate training,
growth consulting, and business consulting, brings reputed companies and firms to us
for business enhancement solutions. We can be your one-stop-shop for Industry
research information and niche market analysis.

To purchase your copy: http://www.marketsmonitor.com/category/Biotech14.html
For more information about the report please visit www.marketsmonitor.com


Web Site = http://www.marketsmonitor.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com